John Segreti to Humans
This is a "connection" page, showing publications John Segreti has written about Humans.
Connection Strength
0.579
-
Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness. Clin Infect Dis. 2023 08 14; 77(3):346-350.
Score: 0.051
-
Introduction to the Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee Guideline for Prevention of Surgical Site Infection: Prosthetic Joint Arthroplasty Section. Surg Infect (Larchmt). 2017 May/Jun; 18(4):394-400.
Score: 0.033
-
Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: An Up-To-Date approach. J Infect Chemother. 2016 Jun; 22(6):351-9.
Score: 0.030
-
Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. J Ocul Pharmacol Ther. 2012 Feb; 28(1):3-11.
Score: 0.022
-
Consensus conference on prevention of central line-associated bloodstream infections: 2009. J Infus Nurs. 2011 Mar-Apr; 34(2):126-33.
Score: 0.021
-
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clin Ther. 2010 Sep; 32(10):1713-9.
Score: 0.021
-
Empirical therapy for serious Gram-positive infections: making the right choice. Clin Microbiol Infect. 2009 Dec; 15 Suppl 6:5-10.
Score: 0.020
-
Review of question and answer session. Int J Antimicrob Agents. 2009 Jul; 34 Suppl 1:S36-8.
Score: 0.019
-
University HealthSystem Consortium quality performance benchmarking study of the insertion and care of central venous catheters. Infect Control Hosp Epidemiol. 2008 May; 29(5):440-2.
Score: 0.018
-
Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care. Crit Care Clin. 2008 Apr; 24(2):249-60, vii-viii.
Score: 0.017
-
Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy. 2006 Mar; 26(3):347-52.
Score: 0.015
-
Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Curr Med Res Opin. 2005 Dec; 21(12):1923-6.
Score: 0.015
-
Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Am J Med. 2005 Jul; 118 Suppl 7A:21S-28S.
Score: 0.014
-
Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2005 Jun; 24(6):405-10.
Score: 0.014
-
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin Microbiol Infect. 2005 May; 11 Suppl 3:29-35.
Score: 0.014
-
Value of an infection control practitioner in improving infection control practices at ambulatory sites. Infect Control Hosp Epidemiol. 2004 Apr; 25(4):348-50.
Score: 0.013
-
2020 Mark Coventry Award: Microorganism-directed oral antibiotics reduce the rate of failure due to further infection after two-stage revision hip or knee arthroplasty for chronic infection: a multicentre randomized controlled trial at a minimum of two years. Bone Joint J. 2020 Jun; 102-B(6_Supple_A):3-9.
Score: 0.010
-
Is antibiotic prophylaxis necessary for preventing prosthetic device infection? Infect Dis Clin North Am. 1999 Dec; 13(4):871-7, vii.
Score: 0.010
-
Infectious diarrhea. Dis Mon. 1999 Jul; 45(7):268-99.
Score: 0.010
-
Hot topics on vertebral osteomyelitis from the International Society of Antimicrobial Chemotherapy. Int J Antimicrob Agents. 2019 Aug; 54(2):125-133.
Score: 0.009
-
Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998 Oct; 27(4):711-3.
Score: 0.009
-
Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago. Antimicrob Agents Chemother. 2018 08; 62(8).
Score: 0.009
-
Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital. Infect Control Hosp Epidemiol. 2018 09; 39(9):1058-1062.
Score: 0.009
-
Hot topics in necrotising skin and soft tissue infections. Int J Antimicrob Agents. 2018 Jul; 52(1):1-10.
Score: 0.009
-
Acute bacterial meningitis. Infect Dis Clin North Am. 1996 Dec; 10(4):797-809.
Score: 0.008
-
Prosthetic joints: shining lights on challenging blind spots. Int J Antimicrob Agents. 2017 Feb; 49(2):153-161.
Score: 0.008
-
In vitro activity of macrolides against intracellular Legionella pneumophila. Diagn Microbiol Infect Dis. 1996 Jul; 25(3):123-6.
Score: 0.008
-
Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin. Am J Med. 1996 Jun 24; 100(6A):45S-51S.
Score: 0.008
-
Hot topics in the diagnosis and management of skin and soft-tissue infections. Int J Antimicrob Agents. 2016 Jul; 48(1):19-26.
Score: 0.008
-
Antibiotic therapy in the allergic patient. Med Clin North Am. 1995 Jul; 79(4):935-42.
Score: 0.007
-
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015 Sep; 59(9):5232-8.
Score: 0.007
-
Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year period. Drugs. 1995; 49 Suppl 2:185-7.
Score: 0.007
-
In vitro activity of FK-037. A parenteral cephalosporin. Diagn Microbiol Infect Dis. 1994 Nov; 20(3):175-9.
Score: 0.007
-
In vitro activity of dirithromycin against Chlamydia trachomatis. Antimicrob Agents Chemother. 1994 Sep; 38(9):2213-4.
Score: 0.007
-
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother. 2013 Dec; 68(12):2921-6.
Score: 0.006
-
In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile. Diagn Microbiol Infect Dis. 1993 Aug-Sep; 17(2):177-9.
Score: 0.006
-
Should draining wounds and sinuses associated with hip and knee arthroplasties be cultured? J Arthroplasty. 2013 Sep; 28(8 Suppl):133-6.
Score: 0.006
-
Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother. 2013 Sep; 57(9):4190-6.
Score: 0.006
-
High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992 Apr; 165(4):667-70.
Score: 0.006
-
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis. Am J Med. 1991 Dec 30; 91(6A):150S-152S.
Score: 0.006
-
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases. Am J Med. 1991 Dec 30; 91(6A):24S-26S.
Score: 0.006
-
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011 Jun; 31(6):527-36.
Score: 0.005
-
Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg. 2010 Dec; 18(12):760-70.
Score: 0.005
-
Microbiologic and clinical epidemiologic characteristics of the Chicago subset of a multistate outbreak of Serratia marcescens bacteremia. Infect Control Hosp Epidemiol. 2010 Nov; 31(11):1191-3.
Score: 0.005
-
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother. 1989 Aug; 33(8):1385-7.
Score: 0.005
-
In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3 Suppl):87S-88S.
Score: 0.005
-
Nosocomial infections and secondary infections in sepsis. Crit Care Clin. 1989 Jan; 5(1):177-89.
Score: 0.005
-
Neuropsychiatric complications of human immunodeficiency virus infection. Compr Ther. 1988 Jul; 14(7):9-15.
Score: 0.004
-
Cubicin Outcomes Registry and Experience (CORE) methodology. Am J Med. 2007 Oct; 120(10 Suppl 1):S4-5.
Score: 0.004
-
Q fever in an American tourist returned from Australia. Travel Med Infect Dis. 2007 May; 5(3):194-5.
Score: 0.004
-
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother. 1997 Sep; 41(9):1965-72.
Score: 0.002
-
Joint infections due to Listeria monocytogenes: case report and review. Clin Infect Dis. 1995 Jun; 20(6):1548-50.
Score: 0.002
-
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents. Antimicrob Agents Chemother. 1993 Jul; 37(7):1444-6.
Score: 0.002
-
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990 Mar; 150(3):541-6.
Score: 0.001